RhumbLine Advisers’s iHuman IH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-820
Closed -$2.05K 4157
2025
Q2
$2.05K Sell
820
-114
-12% -$254 ﹤0.01% 3996
2025
Q1
$1.98K Sell
934
-10,456
-92% -$20.9K ﹤0.01% 3988
2024
Q4
$19.2K Hold
11,390
﹤0.01% 3807
2024
Q3
$26.2K Hold
11,390
﹤0.01% 3787
2024
Q2
$20.4K Hold
11,390
﹤0.01% 3869
2024
Q1
$19.4K Hold
11,390
﹤0.01% 3766
2023
Q4
$35K Buy
11,390
+2,450
+27% +$6.66K ﹤0.01% 3692
2023
Q3
$27K Buy
8,940
+2,065
+30% +$6.38K ﹤0.01% 3739
2023
Q2
$20.4K Buy
+6,875
New +$21.3K ﹤0.01% 3813

Other funds holding IH

RhumbLine Advisers's IH Position: Q3 2025 in Review

RhumbLine Advisers sold out of iHuman (IH) in Q3 2025, closing a stake of 820 shares — an estimated $2.05K sold.

RhumbLine Advisers first reported a position in IH in Q2 2023 and held it in 9 quarters. The position peaked at $35K in Q4 2023. 7 funds tracked by Wall St. Rank hold IH as of Q3 2025.

  • RhumbLine Advisers reported no remaining iHuman position as of Q3 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 820 iHuman shares in Q3 2025, an estimated $2.05K.
  • RhumbLine Advisers first reported a position in iHuman in Q2 2023 and held it in 9 quarters.
  • RhumbLine Advisers's iHuman position peaked at $35K in Q4 2023.
  • 7 funds tracked by Wall St. Rank held iHuman as of Q3 2025.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.